ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,593,976 | -15.9% | 253,712 | -7.4% | 0.00% | -50.0% |
Q1 2024 | $7,837,829 | -7.1% | 274,050 | -0.6% | 0.00% | 0.0% |
Q4 2023 | $8,434,492 | +43.7% | 275,637 | +26.2% | 0.00% | 0.0% |
Q3 2023 | $5,870,288 | -26.2% | 218,470 | -2.0% | 0.00% | -33.3% |
Q2 2023 | $7,951,289 | +35.0% | 222,975 | -3.8% | 0.00% | +50.0% |
Q1 2023 | $5,889,321 | -48.0% | 231,863 | -17.0% | 0.00% | -50.0% |
Q4 2022 | $11,330,071 | +28.3% | 279,341 | +4.6% | 0.00% | +33.3% |
Q3 2022 | $8,830,000 | -6.7% | 267,173 | -0.6% | 0.00% | 0.0% |
Q2 2022 | $9,465,000 | -19.5% | 268,797 | +5.1% | 0.00% | -25.0% |
Q1 2022 | $11,757,000 | -22.1% | 255,643 | +12.3% | 0.00% | -20.0% |
Q4 2021 | $15,097,000 | +7.9% | 227,706 | +1.6% | 0.01% | 0.0% |
Q3 2021 | $13,987,000 | -15.9% | 224,045 | +11.6% | 0.01% | -16.7% |
Q2 2021 | $16,625,000 | -13.2% | 200,735 | -30.5% | 0.01% | -14.3% |
Q1 2021 | $19,146,000 | -0.1% | 288,732 | +15.6% | 0.01% | -12.5% |
Q4 2020 | $19,165,000 | +84.0% | 249,779 | +3.2% | 0.01% | +60.0% |
Q3 2020 | $10,418,000 | -1.1% | 241,963 | -0.8% | 0.01% | 0.0% |
Q2 2020 | $10,537,000 | +161.4% | 243,954 | +74.1% | 0.01% | +150.0% |
Q1 2020 | $4,031,000 | -54.9% | 140,103 | -0.5% | 0.00% | -50.0% |
Q4 2019 | $8,930,000 | +15.4% | 140,792 | -48.7% | 0.00% | 0.0% |
Q3 2019 | $7,740,000 | +30.7% | 274,662 | +22.9% | 0.00% | +33.3% |
Q2 2019 | $5,924,000 | +1722.8% | 223,503 | +1161.1% | 0.00% | – |
Q1 2019 | $325,000 | +70.2% | 17,723 | +15.2% | 0.00% | – |
Q4 2018 | $191,000 | -27.7% | 15,388 | +11.8% | 0.00% | – |
Q3 2018 | $264,000 | +40.4% | 13,770 | 0.0% | 0.00% | – |
Q2 2018 | $188,000 | +506.5% | 13,770 | -17.2% | 0.00% | – |
Q1 2017 | $31,000 | -6.1% | 16,635 | -18.5% | 0.00% | – |
Q4 2016 | $33,000 | -46.8% | 20,401 | +147.2% | 0.00% | – |
Q3 2016 | $62,000 | +40.9% | 8,254 | 0.0% | 0.00% | – |
Q2 2016 | $44,000 | – | 8,254 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
Virtu Financial LLC | 18,008 | $78,000 | 0.00% |